![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, October 08, 2020 6:40:47 PM
Big Pharma are perpetuating false narrative that MONOCLONAL ANTIBODIES are expensive
BioClonetics CEO succeeded "on a limited budget" & at a "fraction of the [projected] cost" to produce "PROPRIETARY TECHNOLOGY FOR PRODUCING FULLY HUMAN MONOCLONAL ANTIBODIES"
BioClonetics has proprietary tech for PRODUCING monoclonal antibodies + patent for mAb "CLONE 3" itself
If Big Pharma or US Gov want a better way to PRODUCE mAbs on a MASS SCALE, then they have to go to BioClonetics for the PROPRIETARY tech!
GOD BLESS AMERICA!!!
https://twitter.com/UncleBillyMoney/status/1314327427284336647?s=20
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM